Uses of immunoconjugates targeting CD138

• 收藏
• 分享

专利权人:

ImmunoGen; Inc.

发明人:

OSTERROTH, Frank,UHEREK, Christoph,BRUECHER, Christoph,DAELKEN, Benjamin,ENGLING, Andre,HAEDER, Thomas,WARTENBERG-DEMAND, Andrea,NIEMANN, Gabriele,ZUBER, Chantal,CZELOTH, Niklas,AIGNER, Silke,ZENG, St

申请号：

AU2013201618

公开号：

AU2013201618B2

申请日:

2013.03.18

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2013201618B220160602.pdf#####ABSTRACT Disclosed are methods and treatment regimes that include the administration of immunconjugates targeting CD138 to combat diseases. The immunoconjugate is either used as the sole active ingredient, as part of a treatment regime or as part of an anticancer combination. 4158342 2 (GHMatters) P88742.AU.1

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/